David Erlinge

David Erlinge's AcademicInfluence.com Rankings

David Erlinge

Philosophy

#7099

World Rank

#10260

Historical Rank

Logic

#4177

World Rank

#5437

Historical Rank

philosophy Degrees

Download Badge

Philosophy

David Erlinge's Degrees

PhD Medicine Lund University
Doctorate Medicine Lund University

Why Is David Erlinge Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David Erlinge's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Targeted temperature management at 33°C versus 36°C after cardiac arrest. (2013) (1861)
Thrombus aspiration during ST-segment elevation myocardial infarction. (2013) (941)
Instantaneous Wave‐free Ratio versus Fractional Flow Reserve to Guide PCI (2017) (617)
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease. (2007) (455)
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial (2010) (443)
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. (2019) (296)
Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease (2017) (290)
Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014 (2017) (270)
Oxygen Therapy in Suspected Acute Myocardial Infarction (2017) (254)
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest. (2021) (253)
Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease (2009) (248)
Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations (2016) (248)
Standardized EEG interpretation accurately predicts prognosis after cardiac arrest (2016) (247)
Platelets activated during myocardial infarction release functional miRNA which can be taken up by endothelial cells and regulate ICAM1 expression (2013) (243)
Cardiospecific microRNA Plasma Levels Correlate with Troponin and Cardiac Function in Patients with ST Elevation Myocardial Infarction, Are Selectively Dependent on Renal Elimination, and Can Be Detected in Urine Samples (2011) (237)
Neuron-Specific Enolase as a Predictor of Death or Poor Neurological Outcome After Out-of-Hospital Cardiac Arrest and Targeted Temperature Management at 33°C and 36°C. (2015) (236)
Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy. (2012) (231)
P2 Receptor Expression Profiles in Human Vascular Smooth Muscle and Endothelial Cells (2002) (220)
A Pilot Study of Rapid Cooling by Cold Saline and Endovascular Cooling Before Reperfusion in Patients With ST-Elevation Myocardial Infarction (2010) (220)
Platelets synthesize large amounts of active plasminogen activator inhibitor 1. (2004) (215)
Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. (2008) (208)
Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo. (2008) (202)
Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. (2010) (194)
Extracellular ATP: a growth factor for vascular smooth muscle cells. (1998) (187)
Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction (2013) (186)
ADP Receptor P2Y12 Is Expressed in Vascular Smooth Muscle Cells and Stimulates Contraction in Human Blood Vessels (2004) (186)
P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells (2004) (184)
Type 2 myocardial infarction in clinical practice (2014) (180)
P2 receptors in cardiovascular regulation and disease (2008) (178)
P2 receptors in cardiovascular regulation and disease (2007) (172)
Neurologic Function and Health-Related Quality of Life in Patients Following Targeted Temperature Management at 33°C vs 36°C After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. (2015) (169)
Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results. (2015) (168)
Target Temperature Management after out-of-hospital cardiac arrest--a randomized, parallel-group, assessor-blinded clinical trial--rationale and design. (2012) (166)
Plasticity of TRPC expression in arterial smooth muscle: correlation with store-operated Ca2+ entry. (2005) (159)
Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden (2013) (155)
Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry. (2016) (141)
Bivalirudin versus Heparin Monotherapy in Myocardial Infarction (2017) (138)
Hemodynamics and Vasopressor Support During Targeted Temperature Management at 33°C Versus 36°C After Out-of-Hospital Cardiac Arrest: A Post Hoc Study of the Target Temperature Management Trial* (2015) (134)
Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest (2019) (134)
Gene expression profiling for the identification of G-protein coupled receptors in human platelets. (2008) (134)
Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. (2019) (123)
Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP (1994) (115)
ADP Acting on P2Y13 Receptors Is a Negative Feedback Pathway for ATP Release From Human Red Blood Cells (2005) (115)
Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. (1998) (114)
Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size (2008) (114)
A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development (1999) (111)
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study (2021) (110)
Positive Inotropic Effects by Uridine Triphosphate (UTP) and Uridine Diphosphate (UDP) via P2Y2 and P2Y6 Receptors on Cardiomyocytes and Release of UTP in Man During Myocardial Infarction (2006) (102)
Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin. (2009) (99)
Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study (2017) (97)
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque. (2020) (96)
Procalcitonin after cardiac arrest - an indicator of severity of illness, ischemia-reperfusion injury and outcome. (2013) (95)
Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. (1993) (95)
Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels (2005) (94)
Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014 (2018) (93)
UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors. (2002) (92)
Survival in patients without acute ST elevation after cardiac arrest and association with early coronary angiography: a post hoc analysis from the TTM trial (2015) (91)
High Glucose Activates Nuclear Factor of Activated T Cells in Native Vascular Smooth Muscle (2006) (91)
Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium‐derived hyperpolarising factor (2003) (90)
Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients. (2013) (86)
Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes. (2018) (85)
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial. (2014) (81)
Quantification of ADP and ATP receptor expression in human platelets (2003) (81)
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. (2011) (81)
Ticagrelor induces adenosine triphosphate release from human red blood cells. (2012) (78)
Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors. (2002) (78)
The association of targeted temperature management at 33 and 36 °C with outcome in patients with moderate shock on admission after out-of-hospital cardiac arrest: a post hoc analysis of the Target Temperature Management trial (2014) (78)
Mild hypothermia reduces acute mortality and improves hemodynamic outcome in a cardiogenic shock pig model. (2010) (77)
Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trial. (2012) (76)
Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease (2008) (75)
Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. (1999) (74)
Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells. (1995) (72)
Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. (2019) (71)
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population (2021) (70)
Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Correlation with autoantibodies and clinical manifestations. (1994) (69)
Targeted Temperature Management at 33°C Versus 36°C and Impact on Systemic Vascular Resistance and Myocardial Function After Out-of-Hospital Cardiac Arrest: A Sub-Study of the Target Temperature Management Trial (2014) (69)
Impact on Long-Term Mortality of Presence of Obstructive Coronary Artery Disease and Classification of Myocardial Infarction. (2016) (68)
A new automatic algorithm for quantification of myocardial infarction imaged by late gadolinium enhancement cardiovascular magnetic resonance: experimental validation and comparison to expert delineations in multi-center, multi-vendor patient data (2016) (68)
Intravascular Ultrasound Guidance Is Associated With Better Outcome in Patients Undergoing Unprotected Left Main Coronary Artery Stenting Compared With Angiography Guidance Alone (2017) (66)
The stable pyrimidines UDPβS and UTPγS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery (2000) (66)
Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction (2013) (65)
Plasma Levels of Liver-Specific miR-122 Is Massively Increased in a Porcine Cardiogenic Shock Model and Attenuated by Hypothermia (2012) (65)
Increased risk of acute myocardial infarction and elevated levels of C-reactive protein in carriers of the Thr-87 variant of the ATP receptor P2Y11. (2006) (64)
Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure. (1999) (64)
Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y11-like receptors. (2005) (62)
Endothelial P2Y receptors induce hyperpolarisation of vascular smooth muscle by release of endothelium-derived hyperpolarising factor. (1999) (62)
DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial. (2014) (62)
Predictive value of interleukin-6 in post-cardiac arrest patients treated with targeted temperature management at 33 °C or 36 °C. (2016) (60)
Ticagrelor Improves Peripheral Arterial Function in Patients with a Previous Acute Coronary Syndrome (2013) (60)
Protein S100 as outcome predictor after out-of-hospital cardiac arrest and targeted temperature management at 33 °C and 36 °C (2017) (59)
The ATP Receptors P2X7 and P2X4 Modulate High Glucose and Palmitate-Induced Inflammatory Responses in Endothelial Cells (2015) (59)
External Validation of the DAPT Score in a Nationwide Population. (2018) (59)
Extracellular Nucleotides ATP and UTP Induce a Marked Acute Release of Tissue-type Plasminogen Activator In Vivo in Man (2001) (59)
Targeted hypothermia versus targeted Normothermia after out-of-hospital cardiac arrest (TTM2): A randomized clinical trial-Rationale and design. (2019) (59)
Cytokines Induce Upregulation of Vascular P2Y2 Receptors and Increased Mitogenic Responses to UTP and ATP (2000) (59)
Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. (2021) (58)
A Common Missense Variant in the ATP Receptor P2X7 Is Associated with Reduced Risk of Cardiovascular Events (2012) (58)
Potent P2Y6 receptor mediated contractions in human cerebral arteries (2003) (57)
Single versus Serial Measurements of Neuron-Specific Enolase and Prediction of Poor Neurological Outcome in Persistently Unconscious Patients after Out-Of-Hospital Cardiac Arrest – A TTM-Trial Substudy (2017) (57)
Intravascular versus surface cooling for targeted temperature management after out-of-hospital cardiac arrest – an analysis of the TTM trial data (2016) (57)
Delay From First Medical Contact to Primary PCI and All‐Cause Mortality: A Nationwide Study of Patients With ST‐Elevation Myocardial Infarction (2014) (57)
Association of Weather With Day-to-Day Incidence of Myocardial Infarction: A SWEDEHEART Nationwide Observational Study (2018) (56)
Contrast-Enhanced CMR Overestimates Early Myocardial Infarct Size: Mechanistic Insights Using ECV Measurements on Day 1 and Day 7. (2015) (56)
Target temperature management of 33°C and 36°C in patients with out-of-hospital cardiac arrest with initial non-shockable rhythm - a TTM sub-study. (2015) (56)
P2U‐receptor mediated endothelium‐dependent but nitric oxide‐independent vascular relaxation (1998) (56)
Kv1.3 is the exclusive voltage-gated K+ channel of platelets and megakaryocytes: roles in membrane potential, Ca2+ signalling and platelet count (2010) (55)
Expression profiling and electrophysiological studies suggest a major role for Orai1 in the store-operated Ca2+ influx pathway of platelets and megakaryocytes (2008) (54)
A pooled analysis of the effect of endovascular cooling on infarct size in patients with ST-elevation myocardial infarction. (2013) (54)
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial (2015) (53)
Mortality and neurological outcome in the elderly after target temperature management for out-of-hospital cardiac arrest. (2015) (52)
Detection by near‐infrared spectroscopy of large lipid cores at culprit sites in patients with non‐st‐segment elevation myocardial infarction and unstable angina (2015) (52)
Association of Circulating MicroRNA-124-3p Levels With Outcomes After Out-of-Hospital Cardiac Arrest: A Substudy of a Randomized Clinical Trial. (2016) (51)
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries. (2016) (51)
Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5'-O-thiodiphosphate and uridine 5'-O-3-thiotriphosphate. (2000) (51)
Non-contact acoustic capture of microparticles from small plasma volumes. (2015) (51)
β‐Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study (2015) (51)
Developments in biobanking workflow standardization providing sample integrity and stability. (2013) (50)
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries. (2016) (50)
ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice (2010) (50)
Treatment patterns and outcomes in patients undergoing percutaneous coronary intervention treated with prasugrel or clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR]). (2014) (50)
Uridine triphosphate (UTP) is released during cardiac ischemia. (2005) (50)
Comparison Between Ticagrelor and Clopidogrel in Elderly Patients With an Acute Coronary Syndrome (2020) (50)
Swedish clinical guidelines—Prevention and management of metabolic risk in patients with severe psychiatric disorders (2010) (49)
Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction (2016) (49)
P2Y receptors contribute to ATP-induced increases in intracellular calcium in differentiated but not undifferentiated PC12 cells (2000) (49)
Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry. (2020) (48)
Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes With Outcomes (2020) (47)
Cardiovascular magnetic resonance of the myocardium at risk in acute reperfused myocardial infarction: comparison of T2-weighted imaging versus the circumferential endocardial extent of late gadolinium enhancement with transmural projection (2010) (46)
Uridine diphosphate (UDP) stimulates insulin secretion by activation of P2Y6 receptors. (2008) (46)
Impact of time to return of spontaneous circulation on neuroprotective effect of targeted temperature management at 33 or 36 degrees in comatose survivors of out-of hospital cardiac arrest. (2015) (46)
Mild hypothermia does not attenuate platelet aggregation and may even increase ADP-stimulated platelet aggregation after clopidogrel treatment (2009) (44)
COOL AMI EU pilot trial: a multicentre, prospective, randomised controlled trial to assess cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction. (2017) (43)
Christmas, national holidays, sport events, and time factors as triggers of acute myocardial infarction: SWEDEHEART observational study 1998-2013 (2018) (43)
Succinate independently stimulates full platelet activation via cAMP and phosphoinositide 3‐kinase‐β signaling (2011) (42)
The brain-enriched microRNA miR-124 in plasma predicts neurological outcome after cardiac arrest (2014) (42)
The reversible oral P2Y12 antagonist AZD6140 inhibits ADP-induced contractions in murine and human vasculature. (2010) (41)
Prognostic impact of early ventricular fibrillation in patients with ST-elevation myocardial infarction treated with primary PCI (2012) (41)
Shear stress modulates endothelial KLF2 through activation of P2X4 (2015) (41)
Rationale and Design of the 'MITOCARE' Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction (2012) (40)
No difference in mortality between men and women after out-of-hospital cardiac arrest. (2015) (40)
The combination of high sensitivity troponin T and copeptin facilitates early rule-out of ACS: a prospective observational study (2013) (39)
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic (2020) (39)
Effect of oxygen therapy on myocardial salvage in ST elevation myocardial infarction: the randomized SOCCER trial (2016) (39)
Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial. (2017) (39)
Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model (2010) (38)
European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes. (2020) (38)
Confirmation of the Intracoronary Near-Infrared Spectroscopy Threshold of Lipid-Rich Plaques That Underlie ST-Segment–Elevation Myocardial Infarction (2016) (38)
Optimal timing of hypothermia in relation to myocardial reperfusion (2011) (38)
Neuropeptide Y-like immunoreactivity and hypertension (1992) (37)
MAPKK-dependent growth factor-induced upregulation of P2Y2 receptors in vascular smooth muscle cells. (1999) (37)
Increased Mitogenic and Decreased Contractile P2 Receptors in Smooth Muscle Cells by Shear Stress in Human Vessels With Intact Endothelium (2003) (37)
Therapeutic Hypothermia for the Treatment of Acute Myocardial Infarction - Combined analysis of the RAPID MI- ICE and the CHILL-MI trials (2015) (37)
Prognostic Determinants of Coronary Atherosclerosis in Stable Ischemic Heart Disease: Anatomy, Physiology, or Morphology? (2016) (37)
Bradycardia During Targeted Temperature Management: An Early Marker of Lower Mortality and Favorable Neurologic Outcome in Comatose Out-of-Hospital Cardiac Arrest Patients* (2016) (36)
CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration (2021) (36)
Selective increase of the contractile response to endothelin-1 in subcutaneous arteries from patients with essential hypertension. (1999) (36)
Ischemic Preconditioning Confers Epigenetic Repression of Mtor and Induction of Autophagy Through G9a‐Dependent H3K9 Dimethylation (2016) (35)
P2Y receptors in health and disease. (2011) (35)
Proteomic profiling of extracellular vesicles reveals additional diagnostic biomarkers for myocardial infarction compared to plasma alone (2019) (35)
Direct or subacute coronary angiography in out-of-hospital cardiac arrest (DISCO)-An initial pilot-study of a randomized clinical trial. (2019) (35)
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design. (2020) (35)
ADP receptor P2Y13 induce apoptosis in pancreatic β-cells (2010) (34)
Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial). (2016) (34)
Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint (2016) (34)
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action (2021) (34)
Mild hypothermia reduces cardiac post-ischemic reactive hyperemia (2007) (33)
Detailed statistical analysis plan for the target temperature management after out-of-hospital cardiac arrest trial (2013) (33)
Comparative Proteomic Analysis of Extracellular Vesicles Isolated by Acoustic Trapping or Differential Centrifugation. (2016) (33)
The stable pyrimidines UDPbetaS and UTPgammaS discriminate between contractile cerebrovascular P2 receptors. (2003) (33)
High glucose and free fatty acids induce beta cell apoptosis via autocrine effects of ADP acting on the P2Y13 receptor (2013) (32)
Time-resolved tracking of the atrioventricular plane displacement in Cardiovascular Magnetic Resonance (CMR) images (2017) (31)
Development of an MRM assay panel with application to biobank samples from patients with myocardial infarction. (2013) (31)
Instantaneous Wave-Free Ratio versus Fractional Flow Reserve guided intervention (iFR-SWEDEHEART): Rationale and design of a multicenter, prospective, registry-based randomized clinical trial. (2015) (30)
Transcriptional down‐regulation of the platelet ADP receptor P2Y12 and clusterin in patients with systemic lupus erythematosus (2004) (30)
Human neuropeptide Y Y1 receptor antisense oligodeoxynucleotide specifically inhibits neuropeptide Y-evoked vasoconstriction. (1993) (29)
Protocol for the development of a CONSORT extension for RCTs using cohorts and routinely collected health data (2018) (29)
Transient and rapid QRS-widening associated with a J-wave pattern predicts impending ventricular fibrillation in experimental myocardial infarction. (2014) (29)
Near‐infrared spectroscopy for intracoronary detection of lipid‐rich plaques to understand atherosclerotic plaque biology in man and guide clinical therapy (2015) (29)
A Review of Mild Hypothermia as an Adjunctive Treatment for ST-Elevation Myocardial Infarction. (2011) (29)
Extracellular Uridine Triphosphate and Adenosine Triphosphate Attenuate Endothelial Inflammation through miR-22-Mediated ICAM-1 Inhibition (2015) (29)
Cocaine- and Amphetamine-regulated Transcript (CART) Protects Beta Cells against Glucotoxicity and Increases Cell Proliferation* (2012) (29)
Serum GFAP and UCH-L1 for the prediction of neurological outcome in comatose cardiac arrest patients. (2020) (28)
Oxygen therapy in ST-elevation myocardial infarction (2018) (28)
Incremental Value of Circulating MiR-122-5p to Predict Outcome after Out of Hospital Cardiac Arrest (2017) (28)
Angiotensin II type 1 receptors stimulate protein synthesis in human cardiac fibroblasts via a Ca2+-sensitive PKC-dependent tyrosine kinase pathway. (2000) (28)
The stable pyrimidines UDPbetaS and UTPgammaS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery. (2000) (27)
Pulmonary blood volume variation decreases after myocardial infarction in pigs: a quantitative and noninvasive MR imaging measure of heart failure. (2010) (27)
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes (2017) (27)
Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor. (1996) (27)
ESC Core Curriculum for the Cardiologist. (2020) (26)
Editor’s Choice-Is the pre-hospital ECG after out-of-hospital cardiac arrest accurate for the diagnosis of ST-elevation myocardial infarction? (2016) (26)
Design of DISCO—Direct or Subacute Coronary Angiography in Out‐of‐Hospital Cardiac Arrest study (2018) (26)
P 2 receptor mRNA expression profiles in human lymphocytes , monocytes and CD 34 + stem and progenitor cells (2004) (26)
Contractions in human coronary bypass vessels stimulated by extracellular nucleotides. (2003) (26)
Coronary artery reperfusion: The ADP receptor P2Y1 mediates early reactive hyperemia in vivo in pigs (2004) (25)
Intracoronary near-infrared spectroscopy and the risk of future cardiovascular events (2019) (25)
Differences in the profile of protection afforded by TRO40303 and mild hypothermia in models of cardiac ischemia/reperfusion injury. (2015) (25)
The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease (2014) (25)
Predictors of ventricular fibrillation at reperfusion in patients with acute ST-elevation myocardial infarction treated by primary percutaneous coronary intervention. (2015) (25)
Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (2019) (25)
Primary and secondary capture of platelets onto inflamed femoral artery endothelium is dependent on P-selectin and PSGL-1. (2008) (25)
Apyrase treatment of myocardial infarction according to a clinically applicable protocol fails to reduce myocardial injury in a porcine model (2010) (25)
Survival of Patients With Angina Pectoris Undergoing Percutaneous Coronary Intervention With Intracoronary Pressure Wire Guidance. (2020) (25)
P2X receptors counteract the vasodilatory effects of endothelium derived hyperpolarising factor. (2000) (24)
Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE‐SWEDEHEART Trial (2019) (23)
Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients (2013) (23)
Experimental validation of contrast-enhanced SSFP cine CMR for quantification of myocardium at risk in acute myocardial infarction (2017) (23)
Contractile effects of neuropeptide Y in human subcutaneous resistance arteries are mediated by Y1 receptors. (1996) (23)
TRITON and Beyond: New Insights into the Profile of Prasugrel (2011) (23)
Infectious complications after out-of-hospital cardiac arrest-A comparison between two target temperatures. (2017) (23)
Neuropeptide Y in sympathetic co-transmission: recent advances in the search for neuropeptide Y antagonists (1994) (22)
Tyrphostin inhibition of ATP‐stimulated DNA synthesis, cell proliferation and Fos‐protein expression in vascular smooth muscle cells (1996) (22)
Congestive heart failure induces downregulation of P2X1-receptors in resistance arteries. (1999) (22)
The Effects of Oxygen Therapy on Myocardial Salvage in ST Elevation Myocardial Infarction Treated with Acute Percutaneous Coronary Intervention: The Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion (SOCCER) Study (2015) (22)
P2Y receptor-induced EDHF vasodilatation is of primary importance for the regulation of perfusion pressure in the peripheral circulation of the rat. (2002) (22)
In vivo receptor characterization of neuropeptide Y‐induced effects in consecutive vascular sections of cat skeletal muscle (1997) (21)
P2Y2 receptor modulates shear stress-induced cell alignment and actin stress fibers in human umbilical vein endothelial cells (2016) (21)
Inhibition of MicroRNA-125a Promotes Human Endothelial Cell Proliferation and Viability through an Antiapoptotic Mechanism (2014) (21)
Extracellular ATP: a central player in the regulation of vascular smooth muscle phenotype. Focus on "Dual role of PKA in phenotype modulation of vascular smooth muscle cells by extracellular ATP". (2004) (21)
High-sensitivity troponin-T as a prognostic marker after out-of-hospital cardiac arrest - A targeted temperature management (TTM) trial substudy. (2016) (20)
Upregulation of a Non‐ETA Receptor in Human Arteries In Vitro (1995) (20)
Effects of endovascular cooling on infarct size in ST‐segment elevation myocardial infarction: A patient‐level pooled analysis from randomized trials (2018) (20)
The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: a retrospective analysis of the FEATHER study. (2014) (20)
No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (2018) (20)
Residual platelet ADP reactivity after clopidogrel treatment is dependent on activation of both the unblocked P2Y1 and the P2Y12 receptor and is correlated with protein expression of P2Y12 (2006) (19)
Therapeutic hypothermia for the treatment of acute myocardial infarction-combined analysis of the RAPID MI-ICE and the CHILL-MI trials. (2014) (19)
Long-Term Effects of Oxygen Therapy on Death or Hospitalization for Heart Failure in Patients With Suspected Acute Myocardial Infarction (2018) (19)
Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) (2021) (19)
The enteric nervous system of P2Y13 receptor null mice is resistant against high-fat-diet- and palmitic-acid-induced neuronal loss (2014) (19)
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction (2017) (19)
Myocardium at risk can be determined by ex vivo T2-weighted magnetic resonance imaging even in the presence of gadolinium: comparison to myocardial perfusion single photon emission computed tomography. (2013) (19)
Acute right ventricular failure caused by concomitant coronary and pulmonary embolism: successful treatment with endovascular coronary and pulmonary thrombectomy (2013) (18)
Clinical use of cangrelor: nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). (2019) (18)
The evaluation of an electrocardiographic myocardial ischemia acuteness score to predict the amount of myocardial salvage achieved by early percutaneous coronary intervention Clinical validation with myocardial perfusion single photon emission computed tomography and cardiac magnetic resonance. (2011) (17)
A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI (2014) (17)
Editor’s Choice- Heparin pre-treatment in patients with ST-segment elevation myocardial infarction and the risk of intracoronary thrombus and total vessel occlusion. Insights from the TASTE trial (2019) (16)
ADP Acting on P 2 Y 13 Receptors Is a Negative Feedback Pathway for ATP Release From Human Red Blood Cells (2005) (16)
Effect of exercise on the plasma vesicular proteome: a methodological study comparing acoustic trapping and centrifugation. (2018) (16)
Effect of Oxygen Therapy on Cardiovascular Outcomes in Relation to Baseline Oxygen Saturation. (2019) (16)
Neuropeptide Y and hypertension. (1995) (16)
5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve. (2022) (16)
Ventilatory settings in the initial 72 h and their association with outcome in out-of-hospital cardiac arrest patients: a preplanned secondary analysis of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trial (2022) (15)
Temperature effects on haemostasis in whole blood from ticagrelor- and aspirin-treated patients with acute coronary syndrome (2015) (15)
The analgesic effect of oxygen during percutaneous coronary intervention (the OXYPAIN Trial) (2013) (15)
A low body temperature on arrival at hospital following out-of-hospital-cardiac-arrest is associated with increased mortality in the TTM-study. (2016) (15)
Clinical and angiographic outcomes of bioabsorbable vs. permanent polymer drug-eluting stents in Sweden: a report from the Swedish Coronary and Angioplasty Registry (SCAAR). (2019) (15)
Short- and Long-Term Clinical Outcomes for Patients With Takotsubo Syndrome and Patients With Myocardial Infarction: A Report From the Swedish Coronary Angiography and Angioplasty Registry. (2021) (15)
Infarct quantification using 3D inversion recovery and 2D phase sensitive inversion recovery; validation in patients and ex vivo (2013) (15)
Extent of Myocardium at Risk for Left Anterior Descending Artery, Right Coronary Artery, and Left Circumflex Artery Occlusion Depicted by Contrast-Enhanced Steady State Free Precession and T2-Weighted Short Tau Inversion Recovery Magnetic Resonance Imaging (2016) (15)
Usefulness of Serum B-Type Natriuretic Peptide Levels in Comatose Patients Resuscitated from Out-of-Hospital Cardiac Arrest to Predict Outcome. (2016) (15)
Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction (2019) (15)
Semi-automated biobank sample processing with a 384 high density sample tube robot used in cancer and cardiovascular studies (2015) (14)
Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease (2014) (14)
Impact of Thrombus Aspiration on Mortality, Stent Thrombosis, and Stroke in Patients With ST‐Segment–Elevation Myocardial Infarction: A Report From the Swedish Coronary Angiography and Angioplasty Registry (2018) (14)
Circadian onset and prognosis of myocardial infarction with non-obstructive coronary arteries (MINOCA) (2019) (14)
Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention (2018) (14)
Fondaparinux or enoxaparin: A comparative study of postoperative bleeding in coronary artery bypass grafting surgery (2010) (14)
Prolonged Tpeak-Tend interval is associated with ventricular fibrillation during reperfusion in ST-elevation myocardial infarction. (2019) (13)
Genes Associated with Increased Fasting Glucose in Patients with Schizophrenia Spectrum Disorders (2016) (13)
Sensory nerve terminal activity in severe hypertension as reflected by circulating calcitonin gene-related peptide (CGRP) and substance P. (1992) (13)
Annual report SWEDEHEART 2012 (2014) (13)
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations. (2015) (13)
The Analgesic Effect of Oxygen in Suspected Acute Myocardial Infarction: A Substudy of the DETO2X-AMI Trial. (2018) (13)
Human endothelin ETA receptor antisense oligodeoxynucleotides inhibit endothelin-1 evoked vasoconstriction. (1994) (13)
Effect of oxygen therapy on chest pain in patients with ST elevation myocardial infarction: results from the randomized SOCCER trial (2018) (12)
The reversible oral P2Y12 antagonist AZD6140 inhibits ADP-induced contractions in murine and human vasculature (2008) (12)
Air pollution in relation to very short-term risk of ST-segment elevation myocardial infarction: Case-crossover analysis of SWEDEHEART. (2019) (12)
Radial artery access is associated with lower mortality in patients undergoing primary PCI: a report from the SWEDEHEART registry (2020) (12)
Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology (2019) (12)
Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention: a SWEDEHEART study. (2017) (12)
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal Trial. (2021) (12)
Progressive increase of the Tpeak-Tend interval is associated with ischaemia-induced ventricular fibrillation in a porcine myocardial infarction model (2018) (11)
Vascular smooth muscle cell proliferation depends on caveolin-1-regulated polyamine uptake (2014) (11)
Attenuation of contractile responses to sympathetic co-transmitters in veins from subjects with essential hypertension (1997) (11)
Proteomics in Hypothermia as Adjunctive Therapy in Patients with ST-Segment Elevation Myocardial Infarction: A CHILL-MI Substudy. (2017) (11)
High-sensitivity troponin T as a diagnostic tool for acute coronary syndrome in the real world: an observational study (2014) (11)
T wave alternans in experimental myocardial infarction: time course and predictive value for the assessment of myocardial damage. (2013) (11)
The Search for Vulnerable Plaque - The Pace Quickens (2013) (11)
Endocardial expression and functional characterization of endothelin-1 (2001) (11)
Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome. (2017) (11)
Circulating Levels of miR-574-5p Are Associated with Neurological Outcome after Cardiac Arrest in Women: A Target Temperature Management (TTM) Trial Substudy (2019) (11)
Coronary liposuction during percutaneous coronary intervention: evidence by near-infrared spectroscopy that aspiration reduces culprit lesion lipid content prior to stent placement. (2015) (11)
Inhibition of angiotensin II-induced contraction by losartan in human coronary arteries. (1998) (11)
Sex-differences in circulating biomarkers during acute myocardial infarction: An analysis from the SWEDEHEART registry (2021) (10)
α‐Trinositol: A Functional (Non‐receptor) Neuropeptide Y Antagonist in Vasculature (1996) (10)
Inhibition of the long non-coding RNA NEAT1 protects cardiomyocytes from hypoxia in vitro via decreased pri-miRNA processing (2020) (10)
Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention (2021) (10)
Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction (2018) (10)
Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT (2016) (10)
Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y12 receptor-mediated platelet aggregation (2012) (10)
Effects of phosphorothioated neuropeptide Y Y1‐receptor antisense oligodeoxynucleotide in conscious rats and in human vessels (1996) (10)
Effect of intravascular cooling on microvascular obstruction (MVO) in conscious patients with ST-elevation myocardial infarction undergoing primary PCI: Results from the COOL AMI EU pilot study. (2019) (10)
The P2Y13 Met-158-Thr Polymorphism, Which Is in Linkage Disequilibrium with the P2Y12 Locus, Is Not Associated with Acute Myocardial Infarction (2008) (10)
ST-segment dynamics during reperfusion period and the size of myocardial injury in experimental myocardial infarction. (2011) (10)
Elevated admission glucose is common and associated with high short-term complication burden after acute myocardial infarction: Insights from the VALIDATE-SWEDEHEART study (2019) (10)
Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction: Rational and feasibility. (2020) (10)
Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: A nationwide Swedish registry report. (2016) (9)
Quantitation of 87 Proteins by nLC-MRM/MS in Human Plasma: Workflow for Large-Scale Analysis of Biobank Samples. (2017) (9)
Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-a case-control study. (2011) (9)
Systematic Coronary Risk Evaluation estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries: A population-based cohort analysis from the Swedish Cardiopulmonary Bioimage Study. (2020) (9)
Quantification of myocardium at risk in myocardial perfusion SPECT by co‐registration and fusion with delayed contrast‐enhanced magnetic resonance imaging – an experimental ex vivo study (2012) (9)
Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia (2020) (9)
Repeated epinephrine doses during prolonged cardiopulmonary resuscitation have limited effects on myocardial blood flow: a randomized porcine study (2014) (9)
Time to start of cardiopulmonary resuscitation and the effect of target temperature management at 33°C and 36°C. (2016) (9)
Association of coronary calcium score with endothelial dysfunction and arterial stiffness. (2020) (9)
The ADP receptor P2Y1 mediates t-PA release in pigs during cardiac ischemia (2007) (9)
Forearm blood flow responses to neuropeptide Y, noradrenaline and adenosine 5'-triphosphate in hypertensive and normotensive subjects. (2000) (8)
Treatment with the C 5 a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model (2010) (8)
Translational platelet research in patients with coronary artery disease: What are the major knowledge gaps? (2012) (8)
Agreement of left ventricular mass in steady state free precession and delayed enhancement MR images: implications for quantification of fibrosis in congenital and ischemic heart disease (2010) (8)
Effects of oxygen therapy on wall‐motion score index in patients with ST elevation myocardial infarction—the randomized SOCCER trial (2017) (8)
Association of acute myocardial infarction with influenza: A nationwide observational study (2020) (8)
MicroRNAs in the failing heart – Novel therapeutic targets? (2014) (8)
Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE) (2021) (8)
The stable pyrimidines UDPbS and UTPgS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery (8)
Microvesicles in plasma reflect coronary flow reserve in patients with cardiovascular disease (2021) (8)
Regional wall function before and after acute myocardial infarction; an experimental study in pigs (2014) (8)
Coronary angiographic findings and outcomes in patients with sudden cardiac arrest without ST-elevation myocardial infarction: A SWEDEHEART study. (2018) (8)
Predictive Value of High-Sensitivity Troponin T for Systolic Dysfunction and Infarct Size (Six Months) After ST-Elevation Myocardial Infarction. (2018) (8)
Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New‐Onset Atrial Fibrillation After Acute Myocardial Infarction (2017) (8)
The association between plasma miR-122-5p release pattern at admission and all-cause mortality or shock after out-of-hospital cardiac arrest (2018) (8)
Design and rationale of FLAVOUR: A phase IIa efficacy study of the 5-lipoxygenase activating protein antagonist AZD5718 in patients with recent myocardial infarction (2020) (7)
Atrial Fibrillation Following Out-of-Hospital Cardiac Arrest and Targeted Temperature Management—Are We Giving It the Attention it Deserves?* (2016) (7)
Bilberry Supplementation after Myocardial Infarction Decreases Microvesicles in Blood and Affects Endothelial Vesiculation (2020) (7)
Downregulation of adenosine and P2X receptor-mediated cardiovascular responses in heart failure rats. (2000) (7)
Ventricular ectopic burden in comatose survivors of out-of-hospital cardiac arrest treated with targeted temperature management at 33°C and 36°C. (2016) (7)
Prevalence and Prognostic Implications of Bundle Branch Block in Comatose Survivors of Out-of-Hospital Cardiac Arrest. (2016) (7)
Hypothermia in cardiogenic shock reduces systemic t-PA release (2011) (7)
Assessment of increasing intravenous adenosine dose in fractional flow reserve (2017) (7)
Reclassification of Treatment Strategy With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A Substudy From the iFR-SWEDEHEART Trial. (2018) (7)
Pregnancy Outcomes in Women After Arterial Switch Operation for Transposition of the Great Arteries: Results From ROPAC (Registry of Pregnancy and Cardiac Disease) of the European Society of Cardiology EURObservational Research Programme (2020) (7)
Protocol for a scoping review to support development of a CONSORT extension for randomised controlled trials using cohorts and routinely collected health data (2018) (7)
Longitudinal left ventricular function is globally depressed within a week of STEMI (2018) (7)
Ticagrelor: a cardiometabolic drug targeting erythrocyte-mediated purinergic signaling? (2020) (7)
Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction: a nationwide population-based study. (2022) (7)
Normalization of qPCR in platelets – YWHAE a potential genericreference gene (2016) (7)
Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction. (2021) (7)
Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction (2020) (6)
Early repolarization pattern on ECG recorded prior to the acute coronary event does not predict ventricular fibrillation during ST-elevation myocardial infarction. (2019) (6)
Osborn waves following out-of-hospital cardiac arrest-Effect of level of temperature management and risk of arrhythmia and death. (2018) (6)
Sex-related response to bivalirudin and unfractionated heparin in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A subgroup analysis of the VALIDATE-SWEDEHEART trial (2018) (6)
Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention. (2021) (6)
The touching story of purinergic signaling in epithelial and endothelial cells (2012) (6)
Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study. (2017) (6)
Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction (2020) (6)
Systematic Coronary Risk Evaluation estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries: A population-based cohort analysis from the Swedish Cardiopulmonary Bioimage Study. (2021) (6)
The Rationale for and Clinical Pharmacology of Prasugrel 5 mg (2017) (6)
Using proximity extension proteomics assay to identify biomarkers associated with infarct size and ejection fraction after ST-elevation myocardial infarction (2020) (6)
Clinical Outcomes with Unselected Use of an Ultrathin-Strut Sirolimus-Eluting Stent: A Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). (2020) (6)
Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients – data from the CHILL-MI, MITOCARE and SOCCER trials (2019) (5)
Increased platelet purinergic sensitivity in peripheral arterial disease – A pilot study (2005) (5)
Oxygen targets and 6-month outcome after out of hospital cardiac arrest: a pre-planned sub-analysis of the targeted hypothermia versus targeted normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial (2022) (5)
QRS broadening due to terminal distortion is associated with the size of myocardial injury in experimental myocardial infarction. (2016) (5)
Selective attenuation of neuropeptide-Y-mediated contractile responses in blood vessels from patients with diabetes mellitus (1995) (5)
Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage (2020) (5)
PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve (2019) (5)
Sunday, 26 August 2012 (2012) (5)
Time to start of cardiopulmonary resuscitation and the effect of target temperature management at 33°C and 36°C (2015) (5)
Mild hypothermia markedly reduces ischemia related coronary t-PA release (2010) (5)
Neuropeptide Y in sympathetic co-transmission—Recent advances in the search for neuropeptide Y antagonists (1994) (5)
Prasugrel 5mg in the very elderly is non-inferior to prasugrel 10mg in non-elderly patients : the generations trial, a pharmacodynamic (PD) study in stable CAD patients (2012) (4)
[Cardiovascular treatment potentials. P2 receptors important for future drugs]. (1999) (4)
Temporal trends in characteristics and outcome of heart failure patients with and without significant coronary artery disease (2022) (4)
Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry. (2018) (4)
Radial versus femoral access in patients with acute coronary syndrome undergoing invasive management: A prespecified subgroup analysis from VALIDATE-SWEDEHEART (2019) (4)
Oxygen Therapy in Myocardial Infarction Patients With or Without Diabetes: A Predefined Subgroup Analysis From the DETO2X-AMI Trial (2019) (4)
Use of proteomics to identify biomarkers associated with chronic kidney disease and long‐term outcomes in patients with myocardial infarction (2020) (4)
Current advances in the use of therapeutic hypothermia. (2013) (4)
Usefulness of High Sensitivity Troponin T to Predict Long-Term Left Ventricular Dysfunction After ST-Elevation Myocardial Infarction. (2020) (4)
TCT-350 Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First 400 Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry (2018) (4)
Correction: The ATP Receptors P2X7 and P2X4 Modulate High Glucose and Palmitate-Induced Inflammatory Responses in Endothelial Cells (2015) (4)
Prevalence and prognostic impact of left ventricular systolic dysfunction after acute myocardial infarction (2020) (4)
2949Air temperature as an external trigger of ST-segment elevation myocardial infarction - a SWEDEHEART nationwide observational study (2017) (4)
Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers. (2021) (4)
Routine Oxygen Therapy Does Not Improve Health-Related Quality of Life in Patients With Acute Myocardial Infarction—Insights From the Randomized DETO2X-AMI Trial (2021) (4)
Oxygen therapy in suspected acute myocardial infarction and concurrent normoxemic chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trial (2020) (4)
Christmas holiday triggers of myocardial infarction (2021) (4)
PRASUGREL 5 MG IN LOW BODY WEIGHT PATIENTS REDUCES PLATELET REACTIVITY TO A SIMILAR EXTENT AS PRASUGREL 10 MG IN HIGHER BODY WEIGHT PATIENTS: RESULTS FROM THE FEATHER TRIAL (2012) (4)
Melatonin receptor 1B gene associated with hyperglycemia in bipolar disorder (2016) (4)
Circulating Levels of Brain-Enriched MicroRNAs Correlate with Neuron Specific Enolase after Cardiac Arrest—A Substudy of the Target Temperature Management Trial † (2020) (4)
Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest: a statistical analysis plan (2020) (4)
Prasugrel 5 mg inhibits platelet P-selectin and GPIIb–IIIa expression in very elderly and non elderly: results from the GENERATIONS trial, a pharmacodynamic study in stable CAD patients (2016) (4)
Comparing Effect Estimates in Randomized Trials and Observational Studies From the Same Population: An Application to Percutaneous Coronary Intervention (2021) (4)
Relationship of Platelet Reactivity With Bleeding Outcomes During Long‐Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non‐ST‐Segment Elevation Acute Coronary Syndromes (2016) (3)
Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis. (2021) (3)
Impact of ischaemic heart disease severity and age on risk of cardiovascular outcome in diabetes patients in Sweden: a nationwide observational study (2019) (3)
Evolution of left ventricular function among subjects with ST-elevation myocardial infarction after percutaneous coronary intervention (2020) (3)
Response by Lindahl et al to Letter Regarding Article, "Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease". (2017) (3)
Poor long‐term prognosis in patients admitted with strong suspicion of acute myocardial infarction but discharged with another diagnosis (2021) (3)
Pharmacokinetics and pharmacodynamics of prasugrel 5 mg in low body weight patients and prasugrel 10 mg in higher body weight patients (2012) (3)
Study of ATP-release from acoustically levitated eryhrocytes (2007) (3)
SerumNeurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest (2018) (3)
Bivalirudin versus heparin with primary percutaneous coronary intervention (2018) (3)
Heparin versus bivalirudin in patients with non ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention - a report from SCAAR (2013) (3)
Rationale and Design of Switch Swedeheart: A Registry-Based, Stepped-Wedge, Cluster-Randomized, Open-Label Multicenter Trial to Compare Prasugrel and Ticagrelor for Treatment of Patients with Acute Coronary Syndrome. (2022) (3)
Anterior STEMI associated with decreased strain in remote cardiac myocardium (2021) (3)
Outcome of percutaneous coronary intervention with the Absorb bioresorbable scaffold: data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). (2017) (3)
Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart) (2022) (3)
Developing cooling strategies targeting the heart in adults and children. (2012) (3)
The association of mode of location activity and mobility with acute coronary syndrome: a nationwide ecological study (2020) (3)
Effects of Bilberry and Oat intake on lipids, inflammation and exercise capacity after Acute Myocardial Infarction (BIOAMI): study protocol for a randomized, double-blind, placebo-controlled trial (2021) (3)
Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST‐elevation myocardial infarction treated with primary percutaneous coronary intervention (2020) (2)
Qualitative assessments of myocardial ischemia by cardiac MRI and coronary stenosis by invasive coronary angiography in relation to quantitative perfusion by positron emission tomography in patients with known or suspected stable coronary artery disease (2018) (2)
Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction: Sex related outcomes from DETO2X-AMI. (2021) (2)
Inhibition of c5a related neutrophil activation by adc-1004 reduces myocardial infarct in a porcine ischemia-reperfusion model (2010) (2)
Erratum: P2 receptors in cardiovascular regulation and disease (Purinergic Signalling 10.1007/s11302-007-9078-7) (2008) (2)
Non-Coding RNAs to Aid in Neurological Prognosis after Cardiac Arrest (2018) (2)
We need intracoronary physiology guidance before percutaneous coronary intervention, but do we need it post-stenting? (2021) (2)
2,2′‐Nitrophenylisatogen potentiates P2X1 receptor mediated vascular contraction and blood pressure elevation (2003) (2)
Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned GPI during primary percutaneous coronary intervention in acute myocardial infarction - a VALIDATE-SWEDEHEART substudy. (2019) (2)
Purinergic and Pyriminergic Activation of the Endothelium in Regulation of Tissue Perfusion (2010) (2)
Mean wall thickness improves characterization and prognosis in left ventricular hypertrophy (2019) (2)
MVnet: automated time-resolved tracking of the mitral valve plane in CMR long-axis cine images with residual neural networks: a multi-center, multi-vendor study (2021) (2)
Congestive heart failure induces downregulation of P2X -receptors in 1 resistance arteries (1999) (2)
Hypothermic versus Normothermic Temperature Control after Cardiac Arrest (2022) (2)
Appropriate coronary revascularization can be accomplished if myocardial perfusion is quantified by positron emission tomography prior to treatment decision (2019) (2)
Sex differences in efficacy of pharmacological therapies in heart failure with reduced ejection fraction: a meta‐analysis (2022) (2)
OUTCOMES IN PATIENTS TREATED WITH TICAGRELOR OR CLOPIDOGREL AFTER ACUTE CORONARY SYNDROME: EXPERIENCES FROM SWEDEHEART REGISTRY (2016) (2)
Regional wall function before and after acute myocardial infarction; an experimental study in pigs (2014) (2)
High glucose and free fatty acids induce beta cell apoptosis via autocrine effects of ADP acting on the P2Y13 receptor (2012) (2)
The first specific antiplatelet antidote. (2015) (2)
Transvenous lead extraction procedures in women based on ESC-EHRA EORP European Lead Extraction ConTRolled ELECTRa registry: is female sex a predictor of complications? (2019) (2)
T WAVE ALTERNANS IN EXPERIMENTAL MYOCARDIAL INFARCTION: TIME COURSE AND PREDICTIVE VALUE FOR THE ASSESSING OF MYOCARDIAL DAMAGE (2013) (2)
Cangrelor for ST-Segment–Elevation Myocardial Infarction: Pharmocodynamic Evidence Is In (2019) (1)
Biomarker Discovery Utilizing Biobanking Archives and the Diagnostic Market (2014) (1)
Proteomic profiling of extracellular vesicles reveals additional diagnostic biomarkers for myocardial infarction compared to plasma alone (2019) (1)
Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report (2021) (1)
2209Oxygen therapy in suspected acute myocardial infarction and concurrent chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trial (2019) (1)
Prognostic value of early sustained ventricular arrhythmias in ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: A substudy of VALIDATE-SWEDEHEART trial (2022) (1)
Abstract 18052: Platelet Activity in Primary Percutaneous Coronary Intervention Patients Randomized to Bivalirudin or Heparin (2017) (1)
1400External validation of the DAPT score in nationwide real-world data: ischemic and bleeding events following coronary stent implantation (2018) (1)
Repolarization and ventricular arrhythmia during targeted temperature management post cardiac arrest. (2021) (1)
Oxygen therapy in patients with ST elevation myocardial infarction based on the culprit vessel: results from the randomized controlled SOCCER trial (2020) (1)
On the Natural History of Coronary Artery Disease: A Longitudinal Nationwide Serial Angiography Study (2022) (1)
REAL-LIFE ASSESSMENT OF CANGRELOR P2Y12-INHIBITION IN PATIENTS WITH ST-SEGMENT-ELEVATION MYOCARDIAL INFARCTION (2016) (1)
Outcome In Relation To Antithrombotic Therapy After Myocardial Infarction And Percutaneous Coronary Intervention In Patients With Atrial Fibrillation (2015) (1)
Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function. (2022) (1)
Terminal T-wave inversion predicts reperfusion tachyarrhythmias in STEMI (2022) (1)
system is strongly associated with vascular disease systemic lupus erythematosus: up-regulation of the type I interferon Platelet transcriptional profile and protein expression in patients with (2011) (1)
Infarct quantification with cardiovascular magnetic resonance using "standard deviation from remote" is unreliable: validation in multi-centre multi-vendor data (2022) (1)
ADP mediates inhibition of insulin secretion by activation of P2Y(13) receptors (2008) (1)
Pretreatment with ticagrelor may offset additional inhibition of platelet and coagulation activation with bivalirudin compared to heparin during primary percutaneous coronary intervention. (2018) (1)
At the center of the circle: purinergic signaling in the autocrine loops of pancreatic islets (2013) (1)
Incidental Findings and Their Handling in the Swedish CArdioPulmonary bioImage Study (SCAPIS) (2016) (1)
Regional differences in the incidence and prognosis of the takotsubo syndrome (2019) (1)
Clinical Outcome of Revascularization Deferral With Instantaneous Wave‐Free Ratio and Fractional Flow Reserve: A 5‐Year Follow‐Up Substudy From the iFR‐SWEDEHEART Trial (2023) (1)
Troponin T levels associated with genetic variants in NOTCH2 and MTNR1B in women with psychosis (2017) (1)
Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy? (2019) (1)
Standardization developments for large scale biobanks in smoking related diseases - a model system for blood sample processing and storage (2013) (1)
Relation of Early Monomorphic Ventricular Tachycardia to Long-Term Mortality in ST-Elevation Myocardial Infarction. (2021) (1)
TCT-3 Pretreatment with P2Y12 receptor antagonists is not associated with improved patency of infarct related-artery in STEMI - A report from SCAAR. (2016) (1)
TICAGRELOR INDUCES ADENOSINE TRIPHOSPHATE RELEASE FROM HUMAN RED BLOOD CELLS (2012) (1)
TCT-725 Point-of-Care Genetic Testing of Eleven CYP2C19 Single Nucleotide Polymorphisms Identifies Extensive and Reduced Metabolizers of Clopidogrel With High Accuracy in Patients With Coronary Artery Disease (2012) (1)
Cost-effectiveness of adding a non-invasive acoustic rule-out test in the evaluation of patients with symptoms suggestive of coronary artery disease: rationale and design of the prospective, randomised, controlled, parallel-group multicenter FILTER-SCAD trial (2021) (1)
Tuesday, 28 August 2012 (2012) (1)
Uninterrupted oral anticoagulant therapy in patients undergoing unplanned percutaneous coronary intervention (2020) (1)
Increased expression of miR-224-5p in circulating extracellular vesicles of patients with reduced coronary flow reserve (2022) (1)
Patient experience of the informed consent process during acute myocardial infarction: a sub-study of the VALIDATE-SWEDEHEART trial (2020) (1)
Early monomorphic ventricular tachycardia is associated with increased long-term mortality in STEMI (2020) (1)
TCT-660 Multicenter Validation of a Near-infrared Spectroscopic Signature of Culprit Lesions Causing ST-segment Elevation Myocardial Infarction: The NIRSTEMI II Study (2013) (1)
Effect of upstream clopidogrel treatment in patients with ST-elevation myocardial infarction undergoing primary PCI (2010) (1)
Pretreatment With P2Y12 Inhibitors in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the Swedish Coronary Angiography and Angioplasty Registry. (2021) (1)
Microparticle analysis of clinical plasma samples using acoustic trapping (2016) (1)
Performance of contrast enhanced SSFP and T2-weighted imaging for determining myocardium at risk in a multi-vendor, multi-center setting- data from the MITOCARE and CHILL-MI trials (2015) (1)
1398Association of key risk factors and their combinations on ischemic outcomes and bleeding in patients with invasively managed myocardial infarction in Sweden (2018) (1)
Clinical Impact of Influenza Vaccination after ST- and Non-ST-segment elevation Myocardial Infarction Insights from the IAMI trial. (2022) (1)
Prognostic effects of pre-hospital and in-hospital therapeutic interventions on 30-days mortality in patients with cardiogenic shock (2010) (1)
Design of clinical cardioprotection trials using CMR: impact of myocardial salvage index and a narrow inclusion window on sample size (2015) (1)
PREHOSPITAL ADMINISTRATION OF HEPARIN REDUCES THE RISK OF VESSEL OCCLUSION IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION: SECONDARY ANALYSIS OF THE TASTE TRIAL (2017) (1)
Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT (2016) (1)
Reduction of microvascular obstruction and myocardial infarct size with hypothermia (2008) (1)
Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome. (2022) (1)
Incidence and outcome of takotsubo syndrome compared to acute myocardial infarction, in men versus women (2019) (1)
Developing clinical trial in acute myocardial infarction. (2011) (1)
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). (2022) (1)
Cold saline and endovascular cooling induces rapid hypothermia before reperfusion in STEMI patients treated with primary PCI, is safe and reduces infarct size with a scattered myocardial salvage (2010) (1)
88Oxygen therapy in myocardial infarction patients with or without diabetes mellitus - A predefined subgroup analysis from the DETO2X-AMI trial (2019) (1)
The evolution of myocardium at risk by T2-STIR MR imaging the first week after acute myocardial ischemia (2016) (1)
EFFICACY, SAFETY AND TOLERABILITY OF THE 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITOR AZD5718 IN PATIENTS WITH RECENT MYOCARDIAL INFARCTION: A PHASE 2A STUDY (FLAVOUR) (2021) (1)
Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results. (2023) (1)
Left ventricular mass and global wall thickness -- prognostic utility and characterization of left ventricular hypertrophy (2022) (1)
TCT-142 Prasugrel 5 mg inhibits platelet GPIIb-IIIa and P-Selectin expression in the very elderly - Results from the GENERATIONS trial, a pharmacodynamic study in stable CAD patients (2013) (0)
Contents of Volume 1 (2005) (2005) (0)
Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI) (2022) (0)
Clopidogrel is associated with weaker platelet inhibition, lower active metabolite concentration and more poor responders in higher body weight patients compared with lower body weight patients (2012) (0)
TCT-7 COOL AMI Pilot - randomized controlled trial of intravascular therapeutic hypothermia (TH) in conscious anterior ST-elevation myocardial infarction (STEMI). Cardiac magnetic resonance (cMR) imaging results of microvascular obstruction (MVO) and ejection fraction (EF) at 4-6 and 30 days (2017) (0)
Statin treatment intensity, discontinuation and long-term outcome in patients with acute myocardial infarction and impaired kidney function. (2023) (0)
Abstract 17909: Ventricular Fibrillation During First 48 Hours of ST-Elevation Myocardial Infarction Treated with Primary Angioplasty Increases In-Hospital Mortality but Does Not Affect One-Year Survival in Patients Discharged Alive (2011) (0)
ACOUSTIC ENRICHMENT OF MICROVESICLES IN PLASMA (2014) (0)
P3685Prolonged Tpeak-Tend interval is associated with ventricular fibrillation during reperfusion in ST-elevation myocardial infarction (2018) (0)
P6425Cardiovascular outcome in type 2 diabetes patients: impact of prior acute cardiac event or stroke vs. coronary artery disease: a Swedish nationwide observational study (2018) (0)
Diagnosis and management of non-STEMI coronary syndromes (2016) (0)
Endocardial extent by contrast enhanced cardiac magnetic resonance imaging is not an accurate method for assessing myocardium at risk; validation with T2-weighted cardiac magnetic resonance imaging (2010) (0)
Long-term survival in patients with coronary artery disease undergoing percutaneous coronary intervention with or without intracoronary pressure wire guidance: a report from SCAAR (2020) (0)
P2X4 receptors mediate atheroprotective gene expression in an in vitro model of steady flow in vascular endothelial cells (696.6) (2014) (0)
Can We Do More for the STEMI Patient than Restore Coronary Blood Flow? (2010) (0)
TCT-577 Coronary Liposuction During Primary Percutaneous Coronary Intervention: Evidence by Near-infrared Spectroscopy that Aspiration Reduces Lipid Core Size Prior to Stent Placement (2013) (0)
NIRS-intravascular imaging to predict coronary events (2019) (0)
Intravascular ultrasound guidance is associated with lower mortality in patients undergoing stenting for unprotected left main coronary artery lesions compared to angiography-guided stent implantation (2016) (0)
Incremental value of global longitudinal strain in long-term risk prediction after acute coronary syndrome. A SWEDEHEART registry based echo study (2022) (0)
Poster 103Prognostic effects of prehospital and in-hospital therapeutic interventions on 30-day mortality in patients with cardiogenic shock (2011) (0)
Mild Hypothermia Increases Adenosine Diphosphate-Stimulated Platelet Aggregation After Clopidogrel Administration in Healthy Volunteers (2009) (0)
Abstract 11982: Impact of Coronary Artery Disease Severity on Risk of Cardiovascular Events in Type 2 Diabetes Patients: A Swedish Nationwide Observational Study (2018) (0)
Abstract 224: Repetitive Doses of Epinephrine Do Not Improve Myocardial Flow and Outcome: A Randomized Porcine Study (2014) (0)
Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System—Insights From the Randomized DETO2X-AMI Trial (2022) (0)
Contents Vol. 118, 2011 (2011) (0)
Registry-based randomized clinical trials in cardiology: opportunities and challenges (2021) (0)
T2-STIR CMR imaging can be used to assess myocardium at risk with gadolinium present in an experimental setting (2013) (0)
New automatic algorithm for segmentation of myocardial scar in both inversion recovery and phase sensitive inversion recovery late gadolinium enhancement: validation against TTC and in multi-center, multi-vendor patient data (2016) (0)
Pharmacological characterization of the P2Y(11) Thr-87 variant (2010) (0)
Clinical and Biomedical Mass Spectrometry: New Frontiers in Drug Developments and Diagnosis (2013) (0)
Aalborg Universitet Design and rationale for the Influenza vaccination After Myocardial Infarction ( IAMI ) trial A registry-based randomized clinical trial (2017) (0)
Cohort profile The ESC-EORP Chronic Ischemic Cardiovascular Disease Long-Term (CICD LT) registry. (2019) (0)
Sex differences in pharmacological therapy among heart failure patients: a systematic review and meta-analysis (2020) (0)
QT prolongation during targeted temperature management at 33 degree C vs. 36 degree C and risk of ventricular arrhythmia by different methods of heart rate correction (2016) (0)
Label-free and non-contact platelet analysis platform (2014) (0)
Semi-automatic segmentation of myocardium at risk from contrast enhanced SSFP images - validation against manual delineation and SPECT (2015) (0)
Acute coronary syndromes Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments : experiences from the SWEDEHEARTregistry 1995 – 2014 (2017) (0)
In hospital complications and short- and long-term mortality in patients with type 1 and type 2 myocardial infarction. Data from the SWEDEHEART registry (2013) (0)
A Comparison of 5 mg Prasugrel With 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients : Pharmacodynamics and Rates of High on-Treatment Reactivity (2012) (0)
Identification and characterization of high-risk ACS patients and evaluation of therapies in these cohorts (2020) (0)
Sex differences in potential triggers of myocardial infarction (2023) (0)
Development of a C5AR antagonist for the treatment of reperfusion injury (2010) (0)
Comparison between ticagrelor and clopidogrel in high bleeding risk patients with acute coronary syndrome (2022) (0)
Background characteristics, treatment and long-term prognosis in patients with significant coronary artery stenosis classified as type 1 or type 2 myocardial infarction. Data from SWEDEHEART registry (2015) (0)
Abstract 3217: Prasugrel 60/10 mg Compared with Clopidogrel 600/75 mg Results in Fewer Poor Responders Using Definitions of Platelet Reactivity Associated with Clinical Outcomes (2007) (0)
P5289Myocardial deformation after ST-elevation infarction measured by CMR feature tracking strain (2019) (0)
Antithrombotic Medication And Outcomes After Myocardial Infarction In Patients With Atrial Fibrillation Not Undergoing Percutaneous Coronary Intervention (2015) (0)
P2124High sensitivity troponin T is a stronger predictor than early infarct size determined by CMR for long-term ejection fraction (2017) (0)
How do we treat patients with type 2 (secondary) myocardial infarction in clinical practice? Data from the SWEDEHEART registry (2013) (0)
Biomarkers associated with vulnerable plaques (2022) (0)
P2Y2 receptor modulates shear stress-induced cell alignment and actin stress fibers in human umbilical vein endothelial cells (2016) (0)
Calendar of Events (2009) (0)
Characteristics and outcomes in patients with atrial fibrillation and acute coronary syndrome treated with ticagrelor and novel oral anticoagulants (2021) (0)
Abstract 153: Timing of Hypothermia to Reduce Infarct Size in St-Elevation Myocardial Infarction and Improve Survival in Cardiogenic Shock (2010) (0)
Heparin pre-treatment in patients with ST elevation myocardial infarction: a cohort study investigating the effects on coronary artery occlusion, mortality, and bleeding (2022) (0)
Ticagrelor Treatment is Associated With Increased Coronary Flow Reserve in Survivors of Myocardial Infarction. (2023) (0)
Type 1 or type 2 myocardial infarction in patients without significant coronary artery disease - do we choose clinical type by chance? : Data from the SWEDEHEART registry (2015) (0)
P2×7 RECEPTOR INHIBITION ATTENUATES HUMAN MACROPHAGE RESPONSE TO OXIDIZED LOW-DENSITY LIPOPROTEIN (2012) (0)
PDB118 OUTCOMES AND HEALTHCARE COSTS FOR PATIENTS WITH TYPE 2 DIABETES UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION IN SWEDEN: A NATIONWIDE OBSERVATIONAL STUDY (2019) (0)
Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II (2022) (0)
Bivalirudin versus UFH with or without GP IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction undergoing primary PCI (2016) (0)
Reliability of estimating left ventricular ejection fraction in clinical routine: a validation study of the SWEDEHEART registry (2022) (0)
Abstract 19243: Late Repolarization During Targeted Temperature Management at 33 Degree C vs. 36 Degree C and Risk of Ventricular Arrhythmia in Post Cardiac Arrest Care (2016) (0)
TCT-566 Clinical use of cangrelor: real world data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) (2018) (0)
Contents Vol. 124, 2013 (2013) (0)
Protocol for the development of a CONSORT extension for RCTs using cohorts and routinely collected health data (2018) (0)
Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial. (2023) (0)
Abstract 10678: Pharmacokinetic and Pharmacodynamic Effects of Prasugrel and Clopidogrel According to CYP2C19 Genotype in Very Elderly and Non-Elderly Patients With Coronary Artery Disease (2012) (0)
P3641Predicting one year mortality and heart failure with artificial intelligence after a myocardial infarction (2018) (0)
TCT-2 Coronary angiographic findings and outcomes in patients with sudden cardiac arrest without ST-elevation myocardial infarction: a SWEDEHEART study (2017) (0)
Acute coronary syndromes Contemporary registries on P 2 Y 12 inhibitors in patients with acute coronary syndromes in Europe : overview and methodological considerations (2015) (0)
Myocardial Reperfusion Injury Exists and is Attenuated by Hypothermia (2008) (0)
Bivalirudin versus Heparin Monotherapy in Myocardial Infarction. (2018) (0)
Patient-oriented risk score for predicting death 1 year after myocardial infarction: the SweDen risk score (2022) (0)
TCT-157 Pretreatment with heparins and glycoprotein IIb/IIIa receptor inhibitors is associated with improved patency of infarct related-artery in STEMI - A report from SCAAR. (2016) (0)
P155Evolution of left ventricular longitudinal and radial function after ST-elevation myocardial infarction (2019) (0)
ATP Release from Red Blood Cells Is Regulated by a Negative Feedback Pathway where ADP Acts on P2Y13 Receptors. (2004) (0)
Syddansk Universitet Design and rationale for the Influenza vaccination After Myocardial Infarction ( IAMI ) trial A registry-based randomized clinical trial (2017) (0)
Background characteristics and prognosis in non-invasively treated patients with type 1 and type 2 myocardial infarction. Data from the SWEDEHEART registry (2015) (0)
Book Review:P2 Purinoceptors: Localization, Function and Transduction Mechanisms. Derek J. Chadwick, Jamie A. Goode (1998) (0)
We need intracoronary physiology guidance before percutaneous coronary intervention, but do we need it post-stenting? (2021) (0)
ECG markers of atrial abnormalities are not associated with new onset atrial fibrillation in patients with acute ST-segment elevation myocardial infarction (2021) (0)
Abstract 275: Gene Expression Profiling of G-protein Coupled Receptors in Human Platelets (2006) (0)
Differences in biomarker concentrations and prediction of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction (2021) (0)
Abstract 18150: Ventricular Arrhythmia During Post Cardiac Arrest Care: Prognostic Importance and Influence of Pre-hospital Defibrillation - A TTM Substudy (2015) (0)
Correction to: Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy? (2019) (0)
DELAY FROM FIRST MEDICAL CONTACT TO PCI AND ALL-CAUSE MORTALITY IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PCI (2013) (0)
Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors ‐ a VALIDATE‐SWEDEHEART Substudy (2021) (0)
P6392Under the weather: acute myocardial infarction and subsequent case fatality with influenza burden - a nationwide observational study (2019) (0)
Infarct size is overestimated by contrast-enhanced CMR in the acute phase but not at 7 days when compared with histopathology (2014) (0)
Platelet C1q, C4 and C3 deposition in SLE and the association to vascular disease – Different mechanisms for complement deposition in arterial and venous thrombosis? (2011) (0)
The SOCCER-study: Effects of Oxygen Therapy on Myocardial Salvage in ST Elevation Myocardial Infarction – A Randomized Trial (2016) (0)
Abstract 14644: Impact of Time to Return of Spontaneous Circulation on Neuro-protective Effect of Target Temperature Management at 33 and 36 Degrees in Comatose Survivors of Out of Hospital Cardiac Arrest (2014) (0)
Use of synthetic peptides for demonstration of retroviral antibodies in systemic lupus erythematosus (1995) (0)
The Authors Reply. (2016) (0)
How much is good enough? Insights from myocardial infarction incidence during COVID-19 pandemic (2021) (0)
Primary and secondary capture of platelets in the femoral artery are mediated by P‐selectin and PSGL‐1 in vivo (2007) (0)
The incidence, time distribution and prognostic value of monomorphic ventricular tachycardia in ST-elevation myocardial infarction: the prespecified analysis of VALIDATE SWEADHEART trial (2021) (0)
[The follow up of patients and their relatives after cardiac arrest varies greatly]. (2015) (0)
Front Cover: Bilberry Supplementation after Myocardial Infarction Decreases Microvesicles in Blood and Affects Endothelial Vesiculation (2020) (0)
INTERNATIONAL PROSPECTIVE VALIDATION OF AN INTRACORONARY NEAR–INFRARED SPECTROSCOPY SIGNATURE OF CULPRIT LESIONS IN ACUTE STEMI (2013) (0)
P3627Characteristics and outcomes following myocardial infarction in patients with schizophrenia (2019) (0)
2207Cardiovascular outcome in THEMIS -like type 2 diabetes patients in Sweden: a nationwide observational study (2019) (0)
P1733Fibroblast growth factor-23 (FGF23), an early biomarker of sublinical kidney dysfunction, is associated with poor prognosis in acute coronary syndrome patients (2018) (0)
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are associated with improved outcome but do not prevent new-onset atrial fibrillation after acute myocardial infarction (2016) (0)
Non-contact acoustic capture of platelet-derived microparticles from small plasma volumes (2015) (0)
Infusion of TRO40303 in patients with ST-elevation myocardial infarction prior to primary percutaneous coronary intervention did not alter levels of inflammatory biomarkers in the MITOCARE study (2016) (0)
TCT-84 Serial NIRS-IVUS Assessment of Changes in Coronary Lumen Area During 2-Year Follow-Up: Insights From the PROSPECT ABSORB Trial (2021) (0)
Reperfusion-induced mitochondrial dysfunction in the porcine heart is reduced by TRO40303 in the area at risk predominantly through preservation of outer mitochondrial membrane intactness (2013) (0)
The enteric nervous system of P2Y13 receptor null mice is resistant against high-fat-diet- and palmitic-acid-induced neuronal loss (2014) (0)
TCT-318 Near-infrared Spectroscopy-derived Maximum Lipid Core Burden Index in the Culprit Plaque of Patients with ST-elevation Myocardial Infarction Increases with Age (2015) (0)
TCT-112 Pretreatment with P2Y12 receptor antagonists is not associated with improved patency of infarct related-artery in NSTEMI - A report from SCAAR. (2016) (0)
Therapeutic Hypothermia as a Treatment of Myocardial Infarction and Cardiogenic Shock (2012) (0)
ST CHANGES IN ELECTROCARDIOGRAPHIC LEADS V4-V6 IN PATIENTS WITH INFERIOR MYOCARDIAL INFARCTION PREDICT EXTENT AND DISTRIBUTION OF ISCHEMIC INJURY AS EVALUATED BY CARDIAC MAGNETIC RESONANCE: ANALYSIS FROM THE MITOCARE STUDY (2018) (0)
Extracellular nucleotide contractions in human coronary bypass vessels (2003) (0)
P3643Assessing the external validity of the VALIDATE trial (2018) (0)
P5541A proteomic analysis of 131 biomarkers in relation to infarct size and long-term ejection fraction assessed by CMR in patients with ST-segment elevation myocardial infarction (2017) (0)
Elevated CA125 is associated with incident heart failure and increased mortality in patients with acute coronary syndrome (2016) (0)
TCT-653 An Intracoronary Near-infrared Spectroscopy Signature of Culprit Lesions in Non-ST-Segment Elevation Myocardial Infarction (2013) (0)
Impact of new onset atrial fibrillation on long-term prognosis in patients with acute ST-segment elevation myocardial infarction (2020) (0)
PATIENT CHARACTERISTICS AND BLEEDING OUTCOMES IN INVASIVELY TREATED ACUTE CORONARY SYNDROME PATIENTS TREATED WITH PRASUGREL OR CLOPIDOGREL (2012) (0)
DYNAMIC QRS-WIDENING AND APPEARANCE OF EARLY REPOLARIZATION PATTERN PREDICT IMPENDING VENTRICULAR FIBRILLATION IN EXPERIMENTAL MYOCARDIAL INFARCTION (2014) (0)
Left ventricular global wall thickness is easily calculated, detects and characterizes hypertrophy, and has prognostic utility (2019) (0)
The Reply. (2017) (0)
Clinical risk factors and P wave indices in prediction of atrial fibrillation development during long-term follow-up after acute ST-segment elevation myocardial infarction (2021) (0)
Pharmacological characterization of the P2Y11 Thr-87 variant (2008) (0)
Abstract 3201: Greater P2Y12 Inhibition With Prasugrel Compared With Clopidogrel in Aspirin-Treated Patients Based on Higher Plasma Concentration of the Active Metabolite. (2007) (0)
Antiplatelet Therapy in Acute Coronary Syndromes (2009) (0)
External validation of the PRECISE-DAPT score in a large nationwide population of myocardial infarction patients: a SWEDEHEART study (2020) (0)
Chapter 17 – Perivascular Peptides (NPY, CGRP, and SP) in Hypertension and Congestive Heart Failure (1993) (0)
TCT-65 Reclassification of revascularization strategy with instantaneous wave-free ratio and fractional flow reserve: A report from the iFR-SWEDEHEART study (2017) (0)
Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarction (2023) (0)
P5346Worst lead residual ST-deviation 60 minutes after primary PCI for STEMI is associated with infarct size and myocardial salvage on cardiac magnetic resonance imaging (2017) (0)
VHRM_A_209003 375..384 (2019) (0)
P5373The patients suffering from VF during STEMI are at risk of recurrent arrhythmic complications in case of repeated ischemic events (2018) (0)
Assessing the external validity of the VALIDATE-SWEDEHEART trial (2020) (0)
Cost-effectiveness of adding a non-invasive acoustic rule-out test in the evaluation of patients with suspected stable angina pectoris. Design of the randomized multicenter FILTER-SCAD trial (2020) (0)
The influence of body weight on the pharmacodynamic response to clopidogrel and prasugrel : an integrated analysis of the FEATHER study (2012) (0)
Missing the Culprit Yellow Plaque (2013) (0)
Diagnostic du risque accru d'infarctus aigu du myocarde (2007) (0)
TCT-79 Changes in Coronary Lipid Composition During 2-Year Follow-Up After Acute Myocardial Infarction: Serial NIRS-IVUS Assessment From the PROSPECT ABSORB Trial (2021) (0)
P2661Ventricular fibrillation during acute STEMI is not associated with early repolarization pattern on ECG recorded prior to the index ischemic episode (2019) (0)
Endovascular Hypothermia in Acute Myocardial Infarctions (2014) (0)
Accuracy of estimating left ventricular ejection fraction in clinical routine. A SWEDEHEART registry validation study (2021) (0)
The relationship between ST-dynamics during reperfusion and the infarct size in experimental myocardial infarction (2011) (0)
Abstract 842: Release of Tissue Plasminogen Activator (t-PA) in Response to Ischemia and Reactive Hyperemia is Mediated by P2Y1 Receptors (2006) (0)
Abstract 270: Targeted Temperature Management at 33 or 36 Degrees in Patients Resuscitated from Out-of-Hospital Cardiac Arrest with Initial Nonshockable Rhythms: Impact on Early Risk Factors (2014) (0)
COMPARATIVE LIPID BURDEN OF CULPRIT LESIONS ACCORDING TO THE CLINICAL PRESENTATION OF ACUTE CORONARY SYNDROME (2014) (0)
Erratum to: Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers. (2021) (0)
Impact of the Extent of Circumferential Plaque on Nonculprit Lesion-Related Events: A PROSPECT Substudy. (2019) (0)
A simplified left ventricular end-diastolic mean wall thickness-to-volume ratio estimated from left ventricular mass and end-diastolic volume distinguishes physiological from pathological hypertrophy (2017) (0)
Interactions between cultured bovine arterial endothelial and smooth muscle cells: studies on uptake and degradation of low density lipoproteins by smooth muscle cells. (1993) (0)
How common is significant coronary artery disease in patients with type 2 myocardial infarction? : Data from the SWEDEHEART registry 2011-2013 (2014) (0)
The Swedish Society of Cardiology. (2013) (0)
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study. (2022) (0)
P6294Incremental value of circulating miR-122-5p to predict outcome after out of hospital cardiac arrest (2017) (0)
The touching story of purinergic signaling in epithelial and endothelial cells (2012) (0)
1028 The hyperenhanced region assessed by ex vivo DE-MRI is consistently larger than infarct size determined by TTC staining in the acute phase of reperfused ischemic myocardial injury (2008) (0)
Shear stress modulates endothelial KLF2 through activation of P2X4 (2015) (0)
Intracoronary Imaging of Proximal Coronary Artery Lesions – A Nationwide Lesion-Level Analysis from SCAAR (2023) (0)
The SweDen risk score- predicting death 1-year after myocardial infarction (2022) (0)
Erratum to: Survival in patients without acute ST elevation after cardiac arrest and association with early coronary angiography: a post hoc analysis from the TTM trial (2015) (0)
Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction? (2022) (0)
TCT-709 Clinical importance of intra-procedural thrombotic events - a VALIDATE SWEDEHEART substudy (2018) (0)
[Mitral valve disease:"Now we can both open and close"]. (2011) (0)
RELATIONSHIP BETWEEN CLOPIDOGREL INDUCED PLATELET P2Y12 INHIBITION AND STENT THROMBOSIS OR MYOCARDIAL INFARCTION AFTER PERCUTANEOUS CORONARY INTERVENTION (2011) (0)
P2-polymorphisms and cardiovascular disease (2008) (0)
Differences in background characteristics between patients with type 1 and type 2 myocardial infarction. Data from the SWEDEHEART registry (2013) (0)
Conventional ECG markers do not predict ventricular fibrillation during ST-elevation myocardial infarction (2013) (0)
P2X7 receptor inhibition attenuates human macrophage response to oxidized low-density lipoprotein (2012) (0)
Abstract 14954: Circulating Cardiospecific MicroRNAs are Associated with Long-term Prognosis Following Myocardial Infarction (2011) (0)
Is heparin sufficient in non-ST-elevation acute coronary syndrome percutaneous coronary intervention? (2013) (0)
Reply to Trimaille et al. (2021) (0)
The extent of myocardium at risk for LAD, RCA and LCx using contrast enhanced SSFP and T2-weighted imaging (2015) (0)
Utilization and outcomes of rotational atherectomy in Sweden (2020) (0)
UPSTREAM CLOPIDOGREL FOLLOWED BY PRE-PCI PRASUGREL GIVES RAPID PLATELET INHIBITION AND REPRESENTS A FEASIBLE OPTION IN STEMI PATIENTS UNDERGOING PRIMARY PCI (2012) (0)
Abstract 13846: The Relationship of Platelet Function Measurements with Bleeding Outcomes During Long-term Treatment with Dual Antiplatelet Therapy in Medically Managed NSTE-ACS Patients (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David Erlinge?

David Erlinge is affiliated with the following schools:

Lund University
University of Copenhagen